Day: January 22, 2026

MAHIA, New Zealand, Jan. 22, 2026 (GLOBE NEWSWIRE) — Rocket Lab Corporation (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, successfully completed its 1st launch of 2026 and its 80th Electron launch overall. The mission ‘The Cosmos Will See You Now’ lifted off today from Rocket Lab Launch Complex 1 in Mahia, New Zealand, at 11:52 pm NZDT (10:52 UTC). The mission successfully deployed two satellites into a 1,050 km circular Earth orbit for Open Cosmos, a first-time dedicated launch customer. This higher-altitude deployment showcased Electron’s wide payload trajectory range, maintaining its reputation as a versatile and dependable small spacecraft launch vehicle that meets diverse mission requirements. Open Cosmos, a pan-European space technology company, offers complete end-to-end...

MITOLINE™ Algorithm Powers Development of First-in-Class Small Molecules Targeting a Mitochondrial Carrier for Inflammatory Metabolic Diseases – A Market Projected to Exceed $120 billion by 2030 Neve Yarak, Israel, Jan. 22, 2026 (GLOBE NEWSWIRE) — N2OFF, Inc. (NASDAQ: NITO) (“N2OFF” and the “Company”), a drug discovery company that is also investing in solar energy assets based on the RTB (Ready to Build) business model, today announced that MitoCareX Bio Ltd. (“MitoCareX Bio”), a specialty biotechnology company developing small‑molecule drugs that target human mitochondrial carriers, its wholly- owned subsidiary, has shown preliminary in vitro data demonstrating inhibition of pro‑inflammatory responses in human immune cells using its proprietary discovery platform. Using MITOLINE™‑derived models, MitoCareX has assembled...

Albert Saporta, Co-CIO GAM AlternativesAlbert Saporta, Co-CIO GAM Alternatives, Group CEO GAM Holding AG, GAM Investment Management (Switzerland) AG, albert.saporta@gam.comRandel Freeman, Co-CIO GAM AlternativesRandel Freeman, Co-CIO GAM Alternatives, GAM InvestmentsAlbert Saporta and Randel Freeman send second open letter citing absence of minority shareholder protections and questions potential Honda-SAMIL ancillary transactions On 21 January 2026 the portfolio managers of the GAM Japan Special Situations Fund, the GAM Special Situations Fund and the GAM Global Opportunities Fund published a second open letter to the Board of Directors of Yutaka Giken Co., Ltd., escalating their concerns regarding the proposed tender offer by Samvardhana Motherson International (‘SAMIL’). This second letter follows the portfolio...

WUXI, China, Jan. 22, 2026 (GLOBE NEWSWIRE) — Mingteng International Corporation Inc. (the “Company” or “Mingteng International”) (Nasdaq: MTEN), an automotive mold developer and supplier in China, today announced that it will effect a reverse stock split of its ordinary shares on a 1-for-200 basis (the “Reverse Stock Split”). The Company’s Class A ordinary shares will begin trading on a post-split basis when the market opens on January 26, 2026. The Company’s Class A ordinary shares will continue to trade on the Nasdaq Capital Market under the symbol “MTEN,” with a new CUSIP number G6S85D117. The Reverse Stock Split has been approved by the Company’s shareholders and the Company’s board of directors. Any fractional shares that would have otherwise resulted from the Reverse Stock Split will be rounded up to the next whole number...

NORWOOD, Mass., Jan. 22, 2026 (GLOBE NEWSWIRE) — MariMed Inc. (“MariMed,” “the Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, today announced the launch of a hemp-derived THC version of its Vibations™ hydrating drink mix brand in Rhode Island. The launch represents a capital-efficient opportunity for the Company to expand Vibations into the rapidly growing hemp THC beverage category through an established retail channel, without incremental cultivation or retail infrastructure investment. MariMed believes hemp-derived THC beverages provide a scalable pathway to incremental revenue and accretive gross margin, while maintaining disciplined capital deployment. Distributing a hemp-derived version of Vibations also advances MariMed’s Expand the Brand strategy, which is focused...

DALLAS, Jan. 22, 2026 (GLOBE NEWSWIRE) — P10, Inc. (NYSE: PX) (the “Company”), a leading private markets solutions provider, today announced it will release its fourth quarter and full year 2025 results on Thursday, February 12, 2026, before U.S. markets open. The upcoming financial results will mark the Company’s inaugural quarterly report and conference call as Ridgepost Capital, Inc., after the new name becomes effective on February 11, 2026. The Company will host an earnings conference call at 8:30 a.m. Eastern Time on February 12, 2026. The webcast may be accessed here. All participants joining by telephone should register here for personal dial-in and PIN numbers. For those unable to participate in the live call, a replay will be made available on the Company’s investor relations page. About P10P10 (NYSE: PX) is a leading...

Amendment reduces and simplifies royalty structure on Teverelix® from ~4% to 2% while preserving global rights and IP control The Company is developing Teverelix® as a first in class market product for Acute Urinary Retention Relapse prevention (AURr) and best in class for prostate cancer patients with high CV risk collectively representing ~US$6 billion in potential market opportunity PHILADELPHIA, Jan. 22, 2026 (GLOBE NEWSWIRE) — Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a precision guided biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics assets, is pleased to announce that its subsidiary, Antev Ltd., has entered into Amendment No. 3 to its license agreement with LifeArc relating to Teverelix, an...

SANTA CLARA, Calif., Jan. 22, 2026 (GLOBE NEWSWIRE) — Applied Materials, Inc. today announced that it will hold its fiscal first quarter 2026 earnings conference call on Thursday, Feb. 12, 2026, at 4:30 p.m. ET / 1:30 p.m. PT. The call will be webcast live at: https://ir.appliedmaterials.com. A replay will be available on the same day beginning at 8:00 p.m. ET / 5:00 p.m. PT. About Applied MaterialsApplied Materials, Inc. (Nasdaq: AMAT) is the leader in materials engineering solutions that are at the foundation of virtually every new semiconductor and advanced display in the world. The technology we create is essential to advancing AI and accelerating the commercialization of next-generation chips. At Applied, we push the boundaries of science and engineering to deliver material innovation that changes the world. Learn more at...

NEW YORK, Jan. 22, 2026 (GLOBE NEWSWIRE) — With Markets and Markets projecting the size of the global artificial intelligence (“AI”) market to surge from US$371 billion in 2025 to US$2.4 trillion by 2032, or growing at a CAGR of 30.6% from 2025 to 2032, Society Pass Incorporated (Nasdaq: SOPA) (the “Company”), Southeast Asia’s next generation digital ecosystem, today announces a US$8.8 million minority investment in emerging AI data centre startup, Sapience AI Inc (“Sapience AI”), as part of its efforts to access the computing ecosystem of the fast-growing regional AI data centre market. Slovakia-based Sapience AI closely partners with Taiwan-based semiconductor suppliers—leveraging deep expertise from leading foundries renowned for producing Nvidia’s cutting-edge chips—and a select network of software technology partners...

Hong Kong S.A.R., Jan. 22, 2026 (GLOBE NEWSWIRE) — PTL Limited (NASDAQ: PTLE) (“PTL” or the “Company”) announced that it received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) on January 20, 2026, indicating that the Company is granted an additional 180 calendar days, until July 13, 2026, to regain compliance with the minimum bid price requirement of $1.00 per share, as stipulated by Nasdaq Listing Rule 5550(a)(2). On July 18, 2025, PTL Limited was notified that the Company’s listed security no longer meets the minimum $1 bid price per share requirement under Nasdaq’s Listing Rules. Despite our efforts, the bid price has not regained compliance within the initial 180-day period, which ended on January 14, 2026. However, Nasdaq Staff has determined that PTL Limited is...